Study Design1
Study Limitations1
Scoring range
Domain | HJHS | mHJHS |
---|---|---|
Duration | 0-1 | 0-1 |
Swelling | 0-3 | 0-3 |
Muscle atrophy | 0-2 | 0-2 |
Flexion loss | 0-3 | 0-3 |
Extension loss | 0-3 | 0-3 |
Strength | 0-4 | 0-4 |
Crepitus of motion | 0-2 | 0-1 |
Joint pain | 0-2 | 0-1 |
Instabilitya | - | 0-1 |
Global gaitb | 0-4 | 0-2 |
Total scorec | 0-124 | 0-116 |
aInstability was scored the same as in the old version of the HJHS: 0=none and 1=significant pathologic joint laxity.1
bGlobal gait was scored as follows: 0=no difficulty with walking or climbing up/down stairs; 1=no difficulty with walking, but difficulty with stairs; 2=difficulty with walking and with stairs.1
cJoint scoring was performed separately for 6 joints (left and right ankle, left and right elbow, left and right knee) with a score range of 0 to 19 plus the gait score (0–2). Score of 0=normal; score of 116=most severe disease.1
HJHS=Hemophilia Joint Health Score; mHJHS=modified Hemophilia Joint Health Score.
Oldenburg J, Kulkarni R, Srivastava A, et al. Haemophilia. 2018;24(1):77-84.
TAKE ME TO THE ARTICLEOldenburg J, Kulkarni R, Srivastava A, et al. Haemophilia. 2018;24(1):77-84.
TAKE ME TO THE ARTICLE